CRL vs QTTB · rev $2.00B vs rev $53.7M
Charles River Laboratories (CRL) versus Q32 Bio Inc (QTTB) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Q32 Bio Inc (QTTB) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported QTTB revenue for 2025-12-31 was $53.7M. Net income was $29.8M. QTTB currently screens at market cap $32.4M.
CRL currently screens at market cap $7.78B. QTTB currently screens at market cap $32.4M.
Not investment advice. Open the CRL and QTTB stock pages for the full models.
Not investment advice.